-
1
-
-
79251490374
-
New Driver mutations in non-small cell lung cancer
-
Pao W, Giard N. New Driver mutations in non-small cell lung cancer. Lancet Oncol. 2011 ; 12: 175-180
-
(2011)
Lancet Oncol
, vol.12
, pp. 175-180
-
-
Pao, W.1
Giard, N.2
-
2
-
-
14944385553
-
Global cancer statistics, 2002
-
Parkin DM, Bray Ferlay FJ, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005 ; 55 (2). 74-108
-
(2005)
CA Cancer J Clin
, vol.55
, Issue.2
, pp. 74-108
-
-
Parkin, D.M.1
Bray Ferlay, F.J.2
Pisani, P.3
-
3
-
-
33745118589
-
-
WHO (accessed on August 2011)
-
WHO. Cancer. World Health Organization, http://www.who.int/mediacentre/ factsheets/fs297/en/, 2006. (accessed on August 2011).
-
(2006)
Cancer. World Health Organization
-
-
-
4
-
-
0035144711
-
Effect of cigarette smoking on major histological types of lung cancer: A meta-analysis
-
Khuder SA. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer. 2001 ; 31: 139-148
-
(2001)
Lung Cancer
, vol.31
, pp. 139-148
-
-
Khuder, S.A.1
-
6
-
-
46249130551
-
Soy phytochemicals decrease non small cell lung cancer growth in female athymic mice
-
Gallo D, Zannoni GF, Stefano ID, Mosca M, Ferlini C, Mantuano E, et al. Soy phytochemicals decrease non small cell lung cancer growth in female athymic mice. J Nutr. 2008 ; 138 (7). 1360-1364
-
(2008)
J Nutr
, vol.138
, Issue.7
, pp. 1360-1364
-
-
Gallo, D.1
Zannoni, G.F.2
Stefano, I.D.3
Mosca, M.4
Ferlini, C.5
Mantuano, E.6
-
7
-
-
9744222928
-
Potential synergy of phytochemicals in cancer prevention: Mechanism of action
-
Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr. 2004 ; 134: 3479S - 3485S
-
(2004)
J Nutr
, vol.134
-
-
Liu, R.H.1
-
8
-
-
51449123628
-
Acetylation of Sirt2 by p300 attenuates its deacetylase activity
-
Han Y, Jin YH, Kim YJ, Kang BY, Choi HJ, Kim DW, et al. Acetylation of Sirt2 by p300 attenuates its deacetylase activity. Biochem Biophys Res Commun. 2008 ; 375: 576-580
-
(2008)
Biochem Biophys Res Commun
, vol.375
, pp. 576-580
-
-
Han, Y.1
Jin, Y.H.2
Kim, Y.J.3
Kang, B.Y.4
Choi, H.J.5
Kim, D.W.6
-
9
-
-
13744264091
-
Epigenetic changes in prostate cancer: Implication for diagnosis and treatment
-
Li LC, Carrol PR, Dahiya R. Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J Nat Cancer Inst. 2005 ; 97: 103-115
-
(2005)
J Nat Cancer Inst
, vol.97
, pp. 103-115
-
-
Li, L.C.1
Carrol, P.R.2
Dahiya, R.3
-
10
-
-
77449099964
-
Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex
-
Li K, Shirley KS, Anait SL. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex. Int J Cancer. 2010 ; 126: 1538-1548
-
(2010)
Int J Cancer
, vol.126
, pp. 1538-1548
-
-
Li, K.1
Shirley, K.S.2
Anait, S.L.3
-
11
-
-
40349089627
-
Epigenetic modulation and cancer: Effect of metabolic syndrome?
-
Rossand SA, Milner JA. Epigenetic modulation and cancer: effect of metabolic syndrome?. Am J Clin Nutr. 2007 ; 86: s872 - s877
-
(2007)
Am J Clin Nutr
, vol.86
-
-
Rossand, S.A.1
Milner, J.A.2
-
12
-
-
0035736138
-
If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells
-
Roninson IB, Broude EV, Chang BD. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat. 2001 ; 4: 303-313
-
(2001)
Drug Resist Updat
, vol.4
, pp. 303-313
-
-
Roninson, I.B.1
Broude, E.V.2
Chang, B.D.3
-
13
-
-
0042734906
-
Micronuclei to detect in vivo chemotherapy damage in a p53 mutated solid tumour
-
Driessens G, Harsan L, Robaye B, Waroquier D, Browaeys P, Giannakopoulos X, et al. Micronuclei to detect in vivo chemotherapy damage in a p53 mutated solid tumour. Brit J Cancer. 2003 ; 89: 727-729
-
(2003)
Brit J Cancer
, vol.89
, pp. 727-729
-
-
Driessens, G.1
Harsan, L.2
Robaye, B.3
Waroquier, D.4
Browaeys, P.5
Giannakopoulos, X.6
-
14
-
-
0037989766
-
Chemoprevention of benzo[a]pyrene-induced lung tumors in mice by the farnesyltransferase inhibitor R1157771
-
Gunning WT, Kramer PM, Lubet RA, Steele VE, End DW. Chemoprevention of benzo[a]pyrene-induced lung tumors in mice by the farnesyltransferase inhibitor R1157771. Clin Cancer Res. 2003 ; 9: 1927-1930
-
(2003)
Clin Cancer Res
, vol.9
, pp. 1927-1930
-
-
Gunning, W.T.1
Kramer, P.M.2
Lubet, R.A.3
Steele, V.E.4
End, D.W.5
-
15
-
-
15744405822
-
Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer
-
Swarnakar S, Ganguly K, Kundu P, Banerjee A, Maity P, Sharma AV. Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem. 2005 ; 280 (10). 9409-9415
-
(2005)
J Biol Chem
, vol.280
, Issue.10
, pp. 9409-9415
-
-
Swarnakar, S.1
Ganguly, K.2
Kundu, P.3
Banerjee, A.4
Maity, P.5
Sharma, A.V.6
-
16
-
-
21744443080
-
Chemoprevention of skin cancer by grape constituent resveratrol; Relevance to human disease
-
Aziz MH, Shaw SR, Wu J, Longley BJ, Ahmad N. Chemoprevention of skin cancer by grape constituent resveratrol; relevance to human disease. FASEB J. 2005 ; 19: 1093-1095
-
(2005)
FASEB J
, vol.19
, pp. 1093-1095
-
-
Aziz, M.H.1
Shaw, S.R.2
Wu, J.3
Longley, B.J.4
Ahmad, N.5
-
17
-
-
0016437314
-
The micronucleus test
-
Schmid W. The micronucleus test. Mutat Res. 1975 ; 31: 9-15
-
(1975)
Mutat Res
, vol.31
, pp. 9-15
-
-
Schmid, W.1
-
18
-
-
77149179813
-
Curcumin as an anti-cancer agent: Review of the gap between basic and clinical applications
-
Bar-Sela G, Epelbaum R, Schaffer M. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr Med Chem. 2010 ; 17 (3). 190-197
-
(2010)
Curr Med Chem
, vol.17
, Issue.3
, pp. 190-197
-
-
Bar-Sela, G.1
Epelbaum, R.2
Schaffer, M.3
-
20
-
-
42749090720
-
Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model
-
Tian B, Wang Z, Zhao Y, Wang D, Li Y, Ma L, et al. Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model. Cancer Lett. 2008 ; 264 (2). 299-308
-
(2008)
Cancer Lett
, vol.264
, Issue.2
, pp. 299-308
-
-
Tian, B.1
Wang, Z.2
Zhao, Y.3
Wang, D.4
Li, Y.5
Ma, L.6
-
21
-
-
0027166048
-
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
-
Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993 ; 74 (4). 609-619
-
(1993)
Cell
, vol.74
, Issue.4
, pp. 609-619
-
-
Oltvai, Z.N.1
Milliman, C.L.2
Korsmeyer, S.J.3
-
22
-
-
33748941764
-
Catalpol modulates the expression of Bcl-2 and Bax and attenuates apoptosis in gerbils after ischemic injury
-
Li DQ, Bao YM, Li Y, Wang CF, Liu Y, An LJ. Catalpol modulates the expression of Bcl-2 and Bax and attenuates apoptosis in gerbils after ischemic injury. Brain Res. 2006 ; 1115 (1). 179-185
-
(2006)
Brain Res
, vol.1115
, Issue.1
, pp. 179-185
-
-
Li, D.Q.1
Bao, Y.M.2
Li, Y.3
Wang, C.F.4
Liu, Y.5
An, L.J.6
-
23
-
-
0030893716
-
CD6 ligation modulates Bcl-2? Bax ratio and protects chronic lymocytic leukemia B cells from apoptosis induced by Anti-IgM
-
Lyda MO, Angelina DS, Miguel AS, Kan M, Mikael J. CD6 ligation modulates Bcl-2? Bax ratio and protects chronic lymocytic leukemia B cells from apoptosis induced by Anti-IgM. Blood. 1997 ; 89 (8). 2833-2841
-
(1997)
Blood
, vol.89
, Issue.8
, pp. 2833-2841
-
-
Lyda, M.O.1
Angelina, D.S.2
Miguel, A.S.3
Kan, M.4
Mikael, J.5
|